Halt cell recycling to treat cancer
February 8, 2021
University of Cincinnati researchers have shown that completely halting a cell recycling process in a very aggressive form of breast cancer may improve outcomes for patients one day.
February 8, 2021
University of Cincinnati researchers have shown that completely halting a cell recycling process in a very aggressive form of breast cancer may improve outcomes for patients one day.
February 19, 2021
This week, more than 130 hospitals, research foundations, fundraising organizations and patient advocacy groups asked the Biden administration to put cancer patients first in the next stage of the rollout. The letter, which was signed by leaders at the UC Cancer Center, says research in the past year shows that COVID-19 patients with cancer have twice the death rate than those without cancer.
March 2, 2021
UC's Mary Mahoney, MD, discusses how the COVID-19 vaccine could impact readings from mammograms.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
December 9, 2020
Children with epilepsy with no previous psychiatric diagnosis have alarmingly high rates of suicidal thoughts and behaviors, new research suggests. UC's Michael Privitera weighs in.
May 27, 2020
A study by University of Cincinnati researchers and three Italian institutions reviewing neuroimaging and neurological symptoms in patients with COVID-19 may shed light on the virus’s impact on the central nervous system.
July 1, 2020
WVXU highlights research by Oluwole Awosika, MD, who is examining how walking backward on a treadmill might help stroke survivors learn to walk again.
July 6, 2020
Krushna Patra, PhD, received one of 10 Career Development Awards from PanCAN to continue his work studying genetic mutations that cause pancreatic cancer.
July 8, 2020
Xiaoyang Qi, PhD, received a $500,000 PanCAN grant to study ways a combination therapy could nudge the immune system to fight pancreatic cancer.